Leisure Capital Management trimmed its holdings in The Allstate Co. (NYSE:ALL – Free Report) by 41.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,631 shares of the insurance provider’s stock after selling 6,109 shares during the period. Leisure Capital Management’s holdings in Allstate were worth $1,664,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of ALL. FSA Wealth Management LLC purchased a new stake in Allstate in the 3rd quarter valued at about $26,000. Northwest Investment Counselors LLC acquired a new position in shares of Allstate in the 3rd quarter worth approximately $28,000. Catalyst Capital Advisors LLC purchased a new position in shares of Allstate during the 3rd quarter worth approximately $29,000. Peoples Bank KS acquired a new stake in Allstate in the 4th quarter valued at approximately $49,000. Finally, Transamerica Financial Advisors Inc. purchased a new stake in Allstate in the third quarter valued at approximately $58,000. 76.47% of the stock is owned by hedge funds and other institutional investors.
Allstate Stock Down 0.6 %
Allstate stock opened at $192.60 on Monday. The stock’s 50 day moving average price is $193.92 and its 200 day moving average price is $188.58. The company has a market cap of $51.00 billion, a PE ratio of 12.47, a price-to-earnings-growth ratio of 1.47 and a beta of 0.52. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The Allstate Co. has a 1-year low of $153.42 and a 1-year high of $209.88.
Allstate Announces Dividend
Analyst Ratings Changes
A number of equities analysts recently commented on ALL shares. Keefe, Bruyette & Woods raised their target price on Allstate from $235.00 to $243.00 and gave the company an “outperform” rating in a report on Friday, January 10th. UBS Group upped their target price on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. boosted their price target on shares of Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. Piper Sandler boosted their price objective on Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 26th. Finally, Barclays dropped their target price on Allstate from $187.00 to $183.00 and set an “underweight” rating on the stock in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $218.13.
Read Our Latest Stock Report on ALL
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Short Selling – The Pros and Cons
- 3X-Leveraged ETFs: Amplify Returns With These 3 Top Picks
- Best Stocks Under $5.00
- 3 Underrated Robotics Stocks Poised for Major Growth
- Consumer Discretionary Stocks Explained
- Reshoring Riches: Investing in Made in America 2.0
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.